Our News & Events

Article

Article | Modulating Blood Tumor Barrier Transcriptional Programs to Enhance Glioblastoma Chemotherapy

Science Advances | Volume 11, Issue 9

Dr. Bin Wu (Phosphorex's Board Member & Founder & CEO of Cytodigm) and Theresa Logan from Phosphorex contributed to this groundbreaking work.

Read more